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e-mail address: ab_gab@hotmail.com (A.G. Salman).Abdelrahman Gaber Salman ⇑, Mahmoud Ahmad Abdel Hamid, Dina Ezzat MansourAbstractAim of work: The aim of our work was to detect any structural or functional visual defects during and in between the attacks in
patients with migraine.
Patient and methods: Sixty patients with migraine as well as sixty age and sex matched controls were included. All cases were
subjected to full ophthalmological examination. Cases with any previously known optic nerve abnormalities or with history of
increased intraocular pressure were excluded from this study. A full threshold 24-2 automated perimetry as well as optical coher-
ence tomography (OCT) were performed for retinal nerve fiber layer (RNFL) thickness. Correlations between results of study group
with migraine and controls were analyzed and recorded.
Results: There was a statistically significant difference between the patients with migraine and the controls in visual field analysis
which was (P < 0.05) for generalized visual field deficits and (P < 0.001) for localized visual field deficits during the attack with no
statistically significant difference in visual field in between the attacks (P > 0.05). OCT RNFL thickness had no statistically significant
difference between migraine and control groups (P > 0.05).
Conclusion: Migraine can cause functional ocular disorder without any structural abnormalities.
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Headache as the presenting symptom to the ophthalmo-
logical clinic is not uncommon and represents an important
complaint that should be treated with extreme care.1
Migraine is a common (10–15% of general population),
chronic neurovascular disorder typically characterized by
recurrent attacks of pulsating headache and autonomic ner-
vous system dysfunction. Most often the headache is unilate-
ral, variable in frequency, and lasts at least for four hours. The
pain is usually throbbing or pulsating, moderate to severe,
and aggravated by physical activity, bright lights, and loud
noises. Associated symptoms are nausea, anorexia, and
photophobia.2Visual symptoms are common in migraine patients, with
most of them experiencing photophobia and mild visual dis-
turbances, a subgroup of persons who experience migraine
with aura, however, may experience more severe visual
symptoms which may be positive such as flashes of light
and zigzags or negative such as paracentral scotomata, as
well as neurological symptoms such as hemiparesis or
dysphasia.3
Patients with migraine have been lately demonstrated to
have an increased prevalence of visual field defects that are
not of a temporary neural origin.4
There are only a few reports in the literature documenting
ocular abnormality in migraine during the attack in a small
sample size.e:
al.com
Visual defects and OCT findings in migraine patients 77This work attempted to study the visual field changes in an
Egyptian sample of patients with migraine, as well as doing,
optical coherence tomography (OCT) which is a non invasive,
non contact technique for structural imaging of the layers of
the retina.Patients and methods
Prospective non randomized case control study was done
for sixty patients with episodes of severe headache recog-
nized and diagnosed by neurologists as migraine and were
referred to us from the neurology clinic of Ain-Shams univer-
sity hospitals and sixty healthy age and sex-matched controls
were included in this study.
Written informed consents were taken from all patients
and acceptance of medical and ethics committee of the hos-
pital to do this study.
All patients suffered from migraine with aura and migraine
without aura diagnosed according to the criteria of the Inter-
national Headache Society 2004.5
Full ophthalmological examinations were done to all our
cases to exclude any abnormalities and to ensure that all
patients had normal optic disk appearance, intraocular pres-
sure within normal range, best corrected visual acuity (BCVA)
of 6/6 in both eyes and refractive errors of less than 4 diop-
ters (D) Spherical error and 1.5 D astigmatism, with special
attention to pupillary response. History was taken to ensure
that all patients were free of systemic diseases and not taking
any systemic medications known to affect visual functions.
None of the migrainous patients were receiving a specific
therapy for migraine, but only simple analgesics. The age of
onset, duration, frequency, predominant side of headache,
presence or absence of aura and family history of migraine
if present were recorded.
A full – threshold, central 24-2 automated static perimetry
was done to all our cases for both eyes of each patient, using
the Humphrey field analyzer II (Humphrey Instruments Inc.,
CA). These perimetric examinations were done for all
patients during the attack of headache and in free periods
after one week or more on at least two occasions; the reliabil-
ity indices must be accepted. The Global indices (mean devi-
ation in decibels (MD), pattern standard deviation (PSD),
corrected pattern standard deviation (CPSD) and results of
glaucoma hemifield test were recorded. The field was consid-
ered beyond normal if; glaucoma hemifield test (GHT) was
outside the normal limits and/or presence of a cluster of 3
or more depressed non edge points (P < 1% in one and
<5% in the others).4 Right and left eye data were analyzed
separately to determine whether unilateral or bilateral
involvement was present. We excluded any patient with
bad reliability indices or who could not perform the test dur-
ing the attack.
Optical coherence tomography (OCT-2000; Humphrey
zeiss instruments) was used in this study to measure the ret-
inal nerve fiber layer (RNFL) thickness for both eyes of each
patient, which was defined as the number of pixels between
the anterior and the posterior edges of the RNFL. Each
patient underwent three circular scans around the center of
the optic disk after pupillary dilatation and the mean of the
three scans provided the mean and quadrant RNFL thickness
measurements were recorded. The RNFL thickness wasdifferentiated from other retinal layers using edge detection
algorithm.
Data were extracted and transposed onto a data sheet,
which were entered into a computer programed with the
SPSS/PC Software 17 Package (SPSS Inc., Chicago, IL,
USA). Record was made of each patient’s name, age, hospital
number, visual field, OCT RNFL thickness, duration, side and
presenting symptom of migraine, recurrence and follow up
for further attacks up to six months. These data were com-
pared using an analysis of variance, P < 0.05 was regarded
as significant and highly significant if P < 0.001.Results
Demographic data of both groups are shown in Table 1.
There were no significant differences in the predominant side
of migraine in all our cases 28 (46.7%) were predominant
right side and 32 (53.3%) were predominant left side.
The frequency of episodes varied between one or more
attacks a week and once a month and the attack of migraine
lasts 4–72 h with a mean of 8.71 ± 1.7 h in patients who had
migraine with aura and 9.51 + 1.2 h in patients who had
migraine without aura. Frequency and duration of the attacks
were not statistically significantly different among both
migraine with and without aura (P > 0.05). There was no fam-
ily history of migraine in all our cases.
The main presenting symptoms were blurring of vision
during the attack of migraine in 48 (80%) cases, 5 (8.3%)
cases with visual field defects and 7 (11.7%) cases presented
with ocular redness, lacrimation and photophobia. Aura was
present in 21 (35%) cases and absent in 39 (65%) cases.
Myopia was the most common refractive error in all our
cases ranging from 2.5 to 3.5 D. BCVA was 6/6 in all
our cases. Anterior segment examination revealed no abnor-
malities except of moderate ocular congestion in 12 cases.
Intraocular pressure was near the high upper normal limit in
3 cases and sluggish pupillary response was recorded in 4
cases during the attack of migraine bilaterally.Changes in field of vision
During the attack of migraine
Significantly lower general retinal sensitivity across the
visual field (P = 0.01) and a high incidence of localized visual
field defects in relation to controls were recorded in our
study. Localized field defects were recorded in 47 (78.3%)
of cases and were unilateral in 36 (60%) of them.
19 (31.7%) of patients had defects simulating the nasal
step of glaucoma (Fig. 1), 9 (15%) had the depressed loca-
tions clustered in the inferior arcuate nerve fiber bundle
region, 18 (30%) had paracentral depression (Fig. 2) and
finally 1 (1.7%) had scattered points of low-moderate proba-
bility with general reduction in retinal sensitivity (Fig. 3).
Peripheral contraction of visual field was present in 43
(71.7%) of our cases.
The deficits in the visual field were not correlated with the
age or sex of the patients nor with the frequency, duration,
presence or absence of the aura, family history or side of
migraine.
Table 1. Comparison of results of migraine group and control group.
Migraine group Control group P value
Age 40.43 + 3.33 years 43.11 + 2.11 years P > 0.05
Sex Male/female = 27/33 Male/female = 24/36 P > 0.05
Refractive error Range 2.5 to 3.5 D Range 1.5 to 3.00 D P > 0.05
Mean 2.75 + 1.2 D Mean 1.75 + 1.7 D
General VFD 40 (66.7%) No deficits P < 0.05
Localized VFD 1 47 (78.3%) No deficits P < 0.001
Peripheral contraction VFD 1 43 (71.7%) No deficits P < 0.001
VFD 2 No deficits No deficits P > 0.05
OCT NFLT average 112.78 + 16.25 um 114.35 + 12.43 um P > 0.05
VFD = visual field deficits, VFD 1 = visual field deficits during the attack, VFD 2 = visual field deficits after the attack, OCT NFLT = optical coherence tomography nerve fiber layer
thickness.
Figure 1. Patient 1-right and left nasal step.
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The visual field deficits disappeared completely in
between the attacks (temporary deficit).
For control group there were no visual field deficits.
OCT revealed no abnormalities in the retinal nerve fiber
thickness among all our cases; it was within normal limit
and no statistically significant difference between migrainous
cases and the control group. Table 1 Thus migraine may be
considered a functional deficit without any structural
abnormalities.Discussion
Most estimates of migraine prevalence range from 12 to
15% with the prevalence for women being about twice for
men6 but there was no significant gender difference in our
patients; being 27 (45%) males and 33 (55%) females.
We found visual field deficits of variable extent during the
attacks of migraine in 47 (78.3%) of patients which disap-peared completely in between the attacks, in agreement with
a relatively recent visual field study suggesting that 20% to
48% of migrainous cases demonstrated visual field deficits.4
If these estimates were representative of migraine patients,
then there was a possibility that between 2.5% to 6% of the
general population might demonstrate some form of visual
field abnormalities in association with migraine.
There were several differences between this study and the
prior ones,1,4,6 most previous studies did not include a com-
parable group of non headache control subjects, nor did they
perform concurrent OCT and visual field examination on the
same group of patients and correlate the findings. To the
best of our knowledge OCT was not performed in any of
the previous studies.
The visual field deficits in our study were not significantly
related to age, sex of patients or to the frequency, duration,
presence or absence of the aura, side of migraine or family
history.
Although other studies suggested that the visual field def-
icits are strictly cortical in origin due to changes in blood flow
within the cortical areas responsible for vision,7 the collabora-
Figure 2. Patient 4-left and right paracentral scotoma.
Figure 3. Patient 3-left and right eye generalized depression.
Visual defects and OCT findings in migraine patients 79tive NTG study found that patients with migraine, particularly
women, experienced a more rapid course of glaucoma pro-
gression than those without a history of migraine.3
In our study, ophthalmological examination revealed nor-
mal intraocular pressure in all cases except three showed
transient high normal pressure during the attack of
headache. Also 19 (31.7%) of our patients had defectssimulating the nasal step of glaucoma and 43 (71.7%) showed
peripheral contraction of visual field during the attack of
headache.
As these visual field deficits were transient and disap-
peared after the attack so it might have a neural origin.
Several mechanisms may play role in the genesis of neural
dysfunction in migraine.
80 A.G. Salman et al.An increase in the aggregation of thrombocytes and the
levels of serotonin during the headache period has been
demonstrated in migraine patients.8 Chemical transmitters
as serotonin might play a role in constriction of large arteries
and dilatation of arterioles and capillaries, in fact, a few cases
of ischemic optic neuropathy have been reported during the
episode of migraine.9
Another study had related the cerebral ischemia found in
migraine to ergotamine therapy (which is a vasospastic
agent).10 In this study, the selected patients did not receive
any specific treatment for migraine, but only simple analge-
sics, therefore our fundus examination findings could not
be related to these medications.
A challenge remains in determining the relationship, if any,
between visual dysfunction in migraine and glaucoma. The
relationship between these two conditions has not been a
simple one, migraine has been suggested as a vascular risk
factor for glaucoma.11
Some authors reported a high frequency of migraine in
normotensive glaucoma (NTG) patients in comparison to
chronic open angle glaucoma, ocular hypertension and nor-
mal patients.12
In our study, OCT revealed normal thickness of retinal
nerve fiber layer which eliminates the possibility of associated
or induced glaucoma. Thus, these visual field deficits may
well be cortical in origin.
Our study findings in conjunction with those of previous
authors suggest that Migraineurs should be excluded from
normative perimetric databases. Claiming that all patients
with such deficits had glaucoma will not be an appropriate
conclusion, a possible relationship between migraine, normo-
tensive glaucoma, open angle glaucoma and vascular condi-
tions of the eye deserves further investigation.
Conclusion
Migraine may cause functional visual deficits as docu-
mented by ophthalmological examination and visual field
examination data during the attack without any structural ret-
inal abnormalities as confirmed by OCT. Further studies
should be performed to find out if these visual field deficitsare of cortical or retinal origin or due to vascular or neural
abnormalities.
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